» Articles » PMID: 37162702

Is There Any Association Between the Frequency of Wet Age-related Macular Degeneration Recurrences and the Seasons of the Year?

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 2023 May 10
PMID 37162702
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate whether a seasonal distribution of the frequency of exudative age-related macular degeneration (wet AMD) recurrences exists.

Methods: In total, 129 eyes with 171 recurrences in patients suffering from wet AMD were included in the study. All the patients had been treated with intravitreal anti-VEGF injections according to Pro Re Nata treatment regimen. Recurrence was defined as the re-detection of sub-retinal fluid, intraretinal fluid, and/or sub-macular hemorrhage in optical coherence tomography scans, after at least two consecutive monthly examinations with a "dry" macula. The year was divided in three 4-month periods (zone A: June-September, zone B: October-January, and zone C: February-May) based on the weather conditions prevailing in each period. Mean temperature and hours of sunlight exposure were the main weather markers recorded.

Results: Eighty-two recurrences (48%) occurred during the period June-September, 50 (29.2%) during the period October-January, and 39 (22.8%) during the period February-May (Chi-square = 17.5, p < 0.001). Among the groups, neither patients' age (78 ± 8 years A, 76 ± 7 years B, and 79 ± 8 years C, p = 0.15) nor gender status (40% men A, 36% men B, and 51% men C, p = 0.35) differed significantly. Mean temperature was 27.6 ± 1.8 °C, 15.1 ± 4.6 °C, and 16.5 ± 4.4 °C in zones A, B, and C, respectively. Hours (h) of sunlight exposure (average hours/month) were 344 ± 34 h, 188 ± 42 h, and 223 ± 57 h in zones A, B, and C.

Conclusion: We demonstrated that the frequency of wet AMD recurrences is significantly elevated during the warmer months, possibly due to the higher levels of UV radiation and mean temperature. Further research is necessary to validate our findings.

Citing Articles

Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis.

Datseris I, Rouvas A, Tzanidaki M, Kardara M, Geros V, Gouliopoulos N Clin Ophthalmol. 2025; 19:217-225.

PMID: 39867345 PMC: 11762261. DOI: 10.2147/OPTH.S494595.

References
1.
Wong W, Su X, Li X, Cheung C, Klein R, Cheng C . Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2):e106-16. DOI: 10.1016/S2214-109X(13)70145-1. View

2.
Klein R, Davis M, Magli Y, Segal P, Klein B, Hubbard L . The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98(7):1128-34. DOI: 10.1016/s0161-6420(91)32186-9. View

3.
Bird A, Bressler N, Bressler S, Chisholm I, Coscas G, Davis M . An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995; 39(5):367-74. DOI: 10.1016/s0039-6257(05)80092-x. View

4.
Sadda S, Guymer R, Holz F, Schmitz-Valckenberg S, Curcio C, Bird A . Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology. 2017; 125(4):537-548. PMC: 11366072. DOI: 10.1016/j.ophtha.2017.09.028. View

5.
de Koning-Backus A, Kiefte-de Jong J, van Rooij J, Amd-Life Team , Uitterlinden A, Voortman T . Lifestyle Intervention Randomized Controlled Trial for Age-Related Macular Degeneration (AMD-Life): Study Design. Nutrients. 2023; 15(3). PMC: 9920008. DOI: 10.3390/nu15030602. View